10-13288402-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006214.4(PHYH):​c.636A>G​(p.Thr212Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.252 in 1,613,770 control chromosomes in the GnomAD database, including 53,733 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6431 hom., cov: 32)
Exomes 𝑓: 0.25 ( 47302 hom. )

Consequence

PHYH
NM_006214.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -3.16

Publications

22 publications found
Variant links:
Genes affected
PHYH (HGNC:8940): (phytanoyl-CoA 2-hydroxylase) This gene is a member of the PhyH family and encodes a peroxisomal protein that is involved in the alpha-oxidation of 3-methyl branched fatty acids. Specifically, this protein converts phytanoyl-CoA to 2-hydroxyphytanoyl-CoA. Mutations in this gene have been associated with Refsum disease (RD) and deficient protein activity has been associated with Zellweger syndrome and rhizomelic chondrodysplasia punctata. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
PHYH Gene-Disease associations (from GenCC):
  • adult Refsum disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Orphanet
  • phytanoyl-CoA hydroxylase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 10-13288402-T-C is Benign according to our data. Variant chr10-13288402-T-C is described in ClinVar as Benign. ClinVar VariationId is 95349.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.388 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHYHNM_006214.4 linkc.636A>G p.Thr212Thr synonymous_variant Exon 6 of 9 ENST00000263038.9 NP_006205.1 O14832-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHYHENST00000263038.9 linkc.636A>G p.Thr212Thr synonymous_variant Exon 6 of 9 1 NM_006214.4 ENSP00000263038.4 O14832-1

Frequencies

GnomAD3 genomes
AF:
0.280
AC:
42556
AN:
152004
Hom.:
6413
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.393
Gnomad AMI
AF:
0.188
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.229
Gnomad EAS
AF:
0.121
Gnomad SAS
AF:
0.158
Gnomad FIN
AF:
0.276
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.258
Gnomad OTH
AF:
0.233
GnomAD2 exomes
AF:
0.233
AC:
58616
AN:
251216
AF XY:
0.228
show subpopulations
Gnomad AFR exome
AF:
0.401
Gnomad AMR exome
AF:
0.188
Gnomad ASJ exome
AF:
0.228
Gnomad EAS exome
AF:
0.0891
Gnomad FIN exome
AF:
0.283
Gnomad NFE exome
AF:
0.257
Gnomad OTH exome
AF:
0.234
GnomAD4 exome
AF:
0.249
AC:
364641
AN:
1461648
Hom.:
47302
Cov.:
38
AF XY:
0.246
AC XY:
179092
AN XY:
727116
show subpopulations
African (AFR)
AF:
0.401
AC:
13425
AN:
33472
American (AMR)
AF:
0.189
AC:
8435
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.226
AC:
5904
AN:
26134
East Asian (EAS)
AF:
0.146
AC:
5804
AN:
39698
South Asian (SAS)
AF:
0.159
AC:
13702
AN:
86244
European-Finnish (FIN)
AF:
0.280
AC:
14929
AN:
53406
Middle Eastern (MID)
AF:
0.198
AC:
1123
AN:
5686
European-Non Finnish (NFE)
AF:
0.258
AC:
286847
AN:
1111896
Other (OTH)
AF:
0.240
AC:
14472
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
14939
29878
44816
59755
74694
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9568
19136
28704
38272
47840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.280
AC:
42622
AN:
152122
Hom.:
6431
Cov.:
32
AF XY:
0.277
AC XY:
20631
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.393
AC:
16303
AN:
41470
American (AMR)
AF:
0.192
AC:
2936
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.229
AC:
796
AN:
3472
East Asian (EAS)
AF:
0.121
AC:
624
AN:
5162
South Asian (SAS)
AF:
0.159
AC:
767
AN:
4824
European-Finnish (FIN)
AF:
0.276
AC:
2922
AN:
10592
Middle Eastern (MID)
AF:
0.235
AC:
69
AN:
294
European-Non Finnish (NFE)
AF:
0.258
AC:
17537
AN:
67994
Other (OTH)
AF:
0.235
AC:
497
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1538
3076
4614
6152
7690
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.255
Hom.:
14922
Bravo
AF:
0.278
Asia WGS
AF:
0.165
AC:
571
AN:
3478
EpiCase
AF:
0.247
EpiControl
AF:
0.236

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 26, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Phytanic acid storage disease Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
1.3
DANN
Benign
0.40
PhyloP100
-3.2
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs473407; hg19: chr10-13330402; COSMIC: COSV53816118; COSMIC: COSV53816118; API